查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1548070

全球幹細胞銀行市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Stem Cell Banking Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球幹細胞銀行市場需求預計將從 2023 年的 89 億美元增至 2032 年的近 194.9 億美元，2024-2032 年研究期間複合年成長率為 9.1%。

幹細胞庫是指在極低的溫度下長期保存從胎盤、臍帶和臍帶組織中提取的幹細胞的過程。這些細胞被儲存用於再生醫學，用於修復受損的組織、器官、移植和治療不同的疾病。幹細胞庫包括收集、處理和保存具有發育不同血液和組織細胞能力的幹細胞。

市場動態

由於慢性疾病盛行率的上升，過去幾年來幹細胞銀行市場正在經歷成長。幹細胞療法在治療一系列致命和慢性疾病方面具有巨大潛力。腎臟疾病、肺部疾病、糖尿病等盛行率的上升正在推動對幹細胞治療的需求。人們對幹細胞治療益處的認知不斷提高，導致對推動幹細胞研究的投資增加。相反，FDA對幹細胞治療的嚴格監管以及與幹細胞庫相關的高營運成本阻礙了市場的成長

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球幹細胞銀行市場的各個細分市場進行了包容性評估。幹細胞銀行產業的成長和趨勢為本研究提供了整體方法。

市場區隔

幹細胞銀行市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按來源

  • 胎盤幹細胞 (PSCS)
  • 脂肪組織源性幹細胞 (ADSCS)
  • 骨髓幹細胞 (BMSCS)
  • 人類胚胎幹細胞 (HESCS)
  • 牙髓幹細胞 (DPSCS)
  • 其他

按服務類型

  • 樣品保存儲存
  • 樣品分析
  • 樣品加工
  • 樣本採集和運輸

按申請

  • 個性化銀行應用程式
  • 研究應用（疾病治療研究、生命科學研究、藥物發現）
  • 臨床應用（造血系統疾病、自體免疫疾病、其他）

按最終用戶

  • 醫院
  • 專科診所
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲幹細胞銀行市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。幹細胞銀行市場的主要參與者包括臍帶血登記（CBR）系統、Cordlife Group Limited、Cryo-Cell International、ViaCord、LifeCell International、StemCyte、Global Cord Blood Corporation、Smart Cells International、Vita34 AG、CryoHoldco（墨西哥） 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：幹細胞銀行 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按來源分類的市場吸引力分析
    • 按服務類型分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球幹細胞銀行市場分析：依來源分類

  • 按來源概述
  • 歷史和預測數據
  • 按來源分析
  • 胎盤幹細胞 (PSCS)
  • 脂肪組織源性幹細胞 (ADSCS)
  • 骨髓幹細胞 (BMSCS)
  • 人類胚胎幹細胞 (HESCS)
  • 牙髓幹細胞 (DPSCS)
  • 其他

第 6 章：全球幹細胞銀行市場分析：依服務類型

  • 按服務類型概述
  • 歷史和預測數據
  • 按服務類型分析
  • 樣品保存儲存
  • 樣品分析
  • 樣品加工
  • 樣本採集和運輸

第 7 章：全球幹細胞銀行市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 個性化銀行應用程式
  • 研究應用（疾病治療研究、生命科學研究、藥物發現）
  • 臨床應用（造血系統疾病、自體免疫疾病、其他）

第 8 章：全球幹細胞銀行市場分析：依最終使用者分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 專科診所
  • 其他

第 9 章：全球幹細胞銀行市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：幹細胞銀行公司的競爭格局

  • 幹細胞銀行市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Cord Blood Registry (CBR) Systems
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cordlife Group Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cryo-Cell International
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ViaCord
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • LifeCell International
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • StemCyte
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Global Cord Blood Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Smart Cells International
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Vita34 AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • CryoHoldco (Mexico)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11211839

The global demand for Stem Cell Banking Market is presumed to reach the market size of nearly USD 19.49 Billion by 2032 from USD 8.9 Billion in 2023 with a CAGR of 9.1% under the study period 2024-2032.

Stem cell banking is the process involving the preservation of stem cells that are extracted from the placenta, umbilical cord and cord tissue at extremely low temperature for a long time period. These cells are storedfor its use in regenerative medicine for repairing damaged tissue, organs, transplanting& treating different diseases. Stem cell banking includes collecting, processing and preserving the stem cells with possess ability to develop different blood and tissue cells.

MARKET DYNAMICS

The stem cell banking market is experiencing growth since past few years owing to rise in prevalence of chronic medical condition. Stem Cell therapy possess high potential in treating range of fatal and chronic medical conditions. Hike in prevalence of kidney diseases, lungs diseases, diabetes, and others, is driving demand for stem cell therapy. Increasing awareness regarding the benefits of stem cell therapy is resulting into higher investment towards pushing the Stem Cell-Based Research. On the contrary side, strict regulation imposed by the FDA on stem cell therapy with high operational cost associated with stem cell banking is hampering the growth of the market

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Stem Cell Banking. The growth and trends of Stem Cell Banking industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Stem Cell Banking market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source

  • Placental Stem Cells (PSCS)
  • Adipose Tissue-derived Stem Cells (ADSCS)
  • Bone Marrow-derived Stem Cells (BMSCS)
  • Human Embryo-derived Stem Cells (HESCS)
  • Dental Pulp-derived Stem Cells (DPSCS)
  • Other

By Service Type

  • Sample Preservation & Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection & Transportation

By Application

  • Personalized Banking Applications
  • Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery)
  • Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other)

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Stem Cell Banking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Stem Cell Banking market include Cord Blood Registry (CBR) Systems, Cordlife Group Limited, Cryo-Cell International, ViaCord, LifeCell International, StemCyte, Global Cord Blood Corporation, Smart Cells International, Vita34 AG, CryoHoldco (Mexico). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. STEM CELL BANKING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Source
    • 3.7.2 Market Attractiveness Analysis By Service Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SOURCE

  • 5.1. Overview By Source
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Source
  • 5.4. Placental Stem Cells (PSCS) Historic and Forecast Sales By Regions
  • 5.5. Adipose Tissue-derived Stem Cells (ADSCS) Historic and Forecast Sales By Regions
  • 5.6. Bone Marrow-derived Stem Cells (BMSCS) Historic and Forecast Sales By Regions
  • 5.7. Human Embryo-derived Stem Cells (HESCS) Historic and Forecast Sales By Regions
  • 5.8. Dental Pulp-derived Stem Cells (DPSCS) Historic and Forecast Sales By Regions
  • 5.9. Other Historic and Forecast Sales By Regions

6. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SERVICE TYPE

  • 6.1. Overview By Service Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Service Type
  • 6.4. Sample Preservation & Storage Historic and Forecast Sales By Regions
  • 6.5. Sample Analysis Historic and Forecast Sales By Regions
  • 6.6. Sample Processing Historic and Forecast Sales By Regions
  • 6.7. Sample Collection & Transportation Historic and Forecast Sales By Regions

7. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Personalized Banking Applications Historic and Forecast Sales By Regions
  • 7.5. Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery) Historic and Forecast Sales By Regions
  • 7.6. Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other) Historic and Forecast Sales By Regions

8. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-user
  • 8.4. Hospitals Historic and Forecast Sales By Regions
  • 8.5. Specialty Clinics Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE STEM CELL BANKING COMPANIES

  • 10.1. Stem Cell Banking Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF STEM CELL BANKING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Cord Blood Registry (CBR) Systems
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Cordlife Group Limited
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Cryo-Cell International
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. ViaCord
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. LifeCell International
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. StemCyte
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Global Cord Blood Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Smart Cells International
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Vita34 AG
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. CryoHoldco (Mexico)
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Source (USD MN)
  • Placental Stem Cells (PSCS) Market Sales By Geography (USD MN)
  • Adipose Tissue-derived Stem Cells (ADSCS) Market Sales By Geography (USD MN)
  • Bone Marrow-derived Stem Cells (BMSCS) Market Sales By Geography (USD MN)
  • Human Embryo-derived Stem Cells (HESCS) Market Sales By Geography (USD MN)
  • Dental Pulp-derived Stem Cells (DPSCS) Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Service Type (USD MN)
  • Sample Preservation & Storage Market Sales By Geography (USD MN)
  • Sample Analysis Market Sales By Geography (USD MN)
  • Sample Processing Market Sales By Geography (USD MN)
  • Sample Collection & Transportation Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Personalized Banking Applications Market Sales By Geography (USD MN)
  • Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery) Market Sales By Geography (USD MN)
  • Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other) Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Stem Cell Banking Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Stem Cell Banking Report
  • Market Research Process
  • Market Research Methodology
  • Global Stem Cell Banking Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Source
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Source (USD MN)
  • Placental Stem Cells (PSCS) Market Sales By Geography (USD MN)
  • Adipose Tissue-derived Stem Cells (ADSCS) Market Sales By Geography (USD MN)
  • Bone Marrow-derived Stem Cells (BMSCS) Market Sales By Geography (USD MN)
  • Human Embryo-derived Stem Cells (HESCS) Market Sales By Geography (USD MN)
  • Dental Pulp-derived Stem Cells (DPSCS) Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Service Type (USD MN)
  • Sample Preservation & Storage Market Sales By Geography (USD MN)
  • Sample Analysis Market Sales By Geography (USD MN)
  • Sample Processing Market Sales By Geography (USD MN)
  • Sample Collection & Transportation Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Personalized Banking Applications Market Sales By Geography (USD MN)
  • Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery) Market Sales By Geography (USD MN)
  • Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other) Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.